메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages 99-107

Going further than Lipinski's rule in drug design

Author keywords

Drug design; Drug likeness; Lipinski; Lipophilicity; Rule of 5

Indexed keywords

MACROCYCLIC COMPOUND; PHOSPHOLIPID;

EID: 84856405594     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2012.648612     Document Type: Review
Times cited : (191)

References (80)
  • 1
    • 0031024171 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • DOI 10.1016/S0169-409X(96)00423-1, PII S0169409X96004231
    • Lipinski C, Lombardo F, Dominy B, Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25 (Pubitemid 27046991)
    • (1997) Advanced Drug Delivery Reviews , vol.23 , Issue.1-3 , pp. 3-25
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 5
    • 9744232909 scopus 로고    scopus 로고
    • Time-related differences in the physical property profiles of oral drugs
    • DOI 10.1021/jm049717d
    • Leeson PD, Davis AM. Time-related differences in the physical property profiles of oral drugs. J Med Chem 2004;47:6338-48 (Pubitemid 39587257)
    • (2004) Journal of Medicinal Chemistry , vol.47 , Issue.25 , pp. 6338-6348
    • Leeson, P.D.1    Davis, A.M.2
  • 6
    • 35748934487 scopus 로고    scopus 로고
    • The influence of drug-like concepts on decision-making in medicinal chemistry
    • DOI 10.1038/nrd2445, PII NRD2445
    • Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 2007;6:881-90 (Pubitemid 350042396)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.11 , pp. 881-890
    • Leeson, P.D.1    Springthorpe, B.2
  • 7
    • 79851508525 scopus 로고    scopus 로고
    • Impact of ion class and time on oral drug molecular properties
    • Leeson P, St-Gallay S. Impact of ion class and time on oral drug molecular properties. Med Chem Commun 2011;2:91-105
    • (2011) Med Chem Commun , vol.2 , pp. 91-105
    • Leeson, P.1    St-Gallay, S.2
  • 8
    • 80053928594 scopus 로고    scopus 로고
    • What do medicinal chemists actually make? A 50-year retrospective
    • Walters WP, Green J, Weiss JR, Murcko MA. What do medicinal chemists actually make? A 50-year retrospective. J Med Chem 2011;54:6405-16
    • (2011) J Med Chem , vol.54 , pp. 6405-6416
    • Walters, W.P.1    Green, J.2    Weiss, J.R.3    Murcko, M.A.4
  • 9
    • 79957698619 scopus 로고    scopus 로고
    • The medicinal Chemist's toolbox: An analysis of reactions used in the pursuit of drug candidates
    • Roughley SD, Jordan AM. The medicinal Chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. J Med Chem 2011;54:3451-79
    • (2011) J Med Chem , vol.54 , pp. 3451-3479
    • Roughley, S.D.1    Jordan, A.M.2
  • 10
    • 84856386727 scopus 로고    scopus 로고
    • World Drug Index
    • World Drug Index. Available from: http://thomsonreuters.com/products- services/science/science-products/az/world-drug-index/
  • 11
    • 0032600640 scopus 로고    scopus 로고
    • A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases
    • Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1999;1:55-68
    • (1999) J Comb Chem , vol.1 , pp. 55-68
    • Ghose, A.K.1    Viswanadhan, V.N.2    Wendoloski, J.J.3
  • 12
    • 0034073605 scopus 로고    scopus 로고
    • Property distribution of drug-related chemical databases
    • DOI 10.1023/A:1008130001697
    • Oprea TI. Property distribution of drug-related chemical databases. J Comput Aided Mol Des 2000;14:251-64 (Pubitemid 30175944)
    • (2000) Journal of Computer-Aided Molecular Design , vol.14 , Issue.3 , pp. 251-264
    • Oprea, T.I.1
  • 13
    • 84856371529 scopus 로고    scopus 로고
    • Comrehensive Medicinal Chemistry Database
    • Comrehensive Medicinal Chemistry Database. Available from: http://accelrys. com/products/databases/bioactivity/comprehensivemedicinal- chemistry.html
  • 14
    • 84856371530 scopus 로고    scopus 로고
    • MACCS Drug Data Report
    • MACCS Drug Data Report. Available from: http://accelrys.com/products/ databases/bioactivity/mddr.html
  • 15
    • 0037208308 scopus 로고    scopus 로고
    • Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry
    • Feher M, Schmidt JM. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Model 2003;43:218-27
    • (2003) J Chem Inf Model , vol.43 , pp. 218-227
    • Feher, M.1    Schmidt, J.M.2
  • 16
    • 71049126548 scopus 로고    scopus 로고
    • Escape from flatland: Increasing saturation as an approach to improving clinical success
    • Lovering F, Bikker J, Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J Med Chem 2009;52:6752-6
    • (2009) J Med Chem , vol.52 , pp. 6752-6756
    • Lovering, F.1    Bikker, J.2    Humblet, C.3
  • 17
    • 70350409235 scopus 로고    scopus 로고
    • The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design?
    • Ritchie TJ, Macdonald SJF. The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design? Drug Discov Today 2009;14:1011-20
    • (2009) Drug Discov Today , vol.14 , pp. 1011-1020
    • Ritchie, T.J.1    Sjf, M.2
  • 18
    • 80052601462 scopus 로고    scopus 로고
    • Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
    • Luker T, Alcaraz L, Chohan KK, et al. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules. Bioorg Med Chem Lett 2011;21:5673-9
    • (2011) Bioorg Med Chem Lett , vol.21 , pp. 5673-5679
    • Luker, T.1    Alcaraz, L.2    Chohan, K.K.3
  • 19
    • 78650459806 scopus 로고    scopus 로고
    • Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles
    • Clemons PA, Bodycombe NE, Carrinski HA, et al. Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc Natl Acad Sci USA 2010;107:18787-92
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 18787-18792
    • Clemons, P.A.1    Bodycombe, N.E.2    Carrinski, H.A.3
  • 20
    • 77955816970 scopus 로고    scopus 로고
    • Distinct biological network properties between the targets of natural products and disease genes
    • Dancik V, Seiler KP, Young DW, et al. Distinct biological network properties between the targets of natural products and disease genes. J Am Chem Soc 2010;132:9259-61
    • (2010) J Am Chem Soc , vol.132 , pp. 9259-9261
    • Dancik, V.1    Seiler, K.P.2    Young, D.W.3
  • 21
    • 0032572816 scopus 로고    scopus 로고
    • A scoring scheme for discriminating between drugs and nondrugs
    • DOI 10.1021/jm9706776
    • Sadowski J, Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J Med Chem 1998;41:3325-9 (Pubitemid 28406539)
    • (1998) Journal of Medicinal Chemistry , vol.41 , Issue.18 , pp. 3325-3329
    • Sadowski, J.1    Kubinyi, H.2
  • 22
    • 0032572819 scopus 로고    scopus 로고
    • Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules?
    • DOI 10.1021/jm970666c
    • Ajay, Walters WP, Murcko MA. Can we learn to distinguish between "Drug-like" and 'Nondrug-like' molecules? J Med Chem 1998;41:3314-24 (Pubitemid 28406538)
    • (1998) Journal of Medicinal Chemistry , vol.41 , Issue.18 , pp. 3314-3324
    • Ajay1    Walters, W.P.2    Murcko, M.A.3
  • 25
    • 35248856018 scopus 로고    scopus 로고
    • A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification
    • DOI 10.1021/ci700107y
    • Li Q, Bender A, Pei J, Lai L. A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification. J Chem Inf Model 2007;47:1776-86 (Pubitemid 47561125)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.5 , pp. 1776-1786
    • Li, Q.1    Bender, A.2    Pei, J.3    Lai, L.4
  • 26
    • 77949822709 scopus 로고    scopus 로고
    • Predicting oral druglikeness by iterative stochastic elimination
    • Rayan A, Marcus D, Goldblum A. Predicting oral druglikeness by iterative stochastic elimination. J Chem Inf Model 2010;50:437-45
    • (2010) J Chem Inf Model , vol.50 , pp. 437-445
    • Rayan, A.1    Marcus, D.2    Goldblum, A.3
  • 27
    • 0141994392 scopus 로고    scopus 로고
    • Drugs and nondrugs: An effective discrimination with topological methods and artificial neural networks
    • Murcia-Soler M, Perez-Gimenez F, Garcia-March FJ, et al. Drugs and nondrugs: an effective discrimination with topological methods and artificial neural networks. J Chem Inf Model 2003;43:1688-702
    • (2003) J Chem Inf Model , vol.43 , pp. 1688-1702
    • Murcia-Soler, M.1    Perez-Gimenez, F.2    Garcia-March, F.J.3
  • 29
    • 33846886129 scopus 로고    scopus 로고
    • Separating drugs from nondrugs: A statistical approach using atom pair distributions
    • DOI 10.1021/ci600329u
    • Hutter MC. Separating drugs from nondrugs: a statistical approach using atom pair distributions. J Chem Inf Model 2007;47:186-94 (Pubitemid 46225575)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.1 , pp. 186-194
    • Hutter, M.C.1
  • 32
    • 0037124196 scopus 로고    scopus 로고
    • Drugs, leads, and drug-likeness: An analysis of some recently launched drugs
    • DOI 10.1016/S0960-894X(02)00244-5, PII S0960894X02002445
    • Proudfoot JR. Drugs, leads, and druglikeness: an analysis of some recently launched drugs. Bioorg Med Chem Lett 2002;12:1647-50 (Pubitemid 34569263)
    • (2002) Bioorganic and Medicinal Chemistry Letters , vol.12 , Issue.12 , pp. 1647-1650
    • Proudfoot, J.R.1
  • 34
    • 0035324944 scopus 로고    scopus 로고
    • Molecular complexity and its impact on the probability of finding leads for drug discovery
    • Hann M, Leach A, Harper G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 2001;41:856-64
    • (2001) J Chem Inf Comput Sci , vol.41 , pp. 856-864
    • Hann, M.1    Leach, A.2    Harper, G.3
  • 35
    • 0035438391 scopus 로고    scopus 로고
    • Is there a difference between leads and drugs? A historical perspective
    • Oprea TI, Davis AM, Teague SJ, Leeson PD. Is there a difference between leads and drugs? A historical perspective. J Chem Inf Model 2001;41:1308-15
    • (2001) J Chem Inf Model , vol.41 , pp. 1308-1315
    • Oprea, T.I.1    Davis, A.M.2    Teague, S.J.3    Leeson, P.D.4
  • 36
    • 77950560159 scopus 로고    scopus 로고
    • An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs
    • Perola E. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs. J Med Chem 2010;53:2986-97
    • (2010) J Med Chem , vol.53 , pp. 2986-2997
    • Perola, E.1
  • 37
    • 2942564021 scopus 로고    scopus 로고
    • Pursuing the leadlikeness concept in pharmaceutical research
    • DOI 10.1016/j.cbpa.2004.04.003, PII S1367593104000493
    • Hann MM, Oprea TI. Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 2004;8:255-63 (Pubitemid 38759400)
    • (2004) Current Opinion in Chemical Biology , vol.8 , Issue.3 , pp. 255-263
    • Hann, M.M.1    Oprea, T.I.2
  • 38
    • 33847381100 scopus 로고    scopus 로고
    • A decade of fragment-based drug design: Strategic advances and lessons learned
    • DOI 10.1038/nrd2220, PII NRD2220
    • Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 2007;6:211-19 (Pubitemid 46344625)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.3 , pp. 211-219
    • Hajduk, P.J.1    Greer, J.2
  • 39
    • 0141726877 scopus 로고    scopus 로고
    • A 'Rule of Three' for fragment-based lead discovery?
    • DOI 10.1016/S1359-6446(03)02831-9, PII S1359644603028319
    • Congreve M, Carr R, Murray C, Jhoti H. A "rule of three" for fragment-based lead discovery? Drug Discov Today 2003;8:876-7 (Pubitemid 37194496)
    • (2003) Drug Discovery Today , vol.8 , Issue.19 , pp. 876-877
    • Congreve, M.1    Carr, R.2    Murray, C.3    Jhoti, H.4
  • 40
    • 33845364148 scopus 로고    scopus 로고
    • Fragment-based drug design: How big is too big?
    • DOI 10.1021/jm060511h
    • Hajduk PJ. Fragment-based drug design: how big is too big? J Med Chem 2006;49:6972-6 (Pubitemid 44885985)
    • (2006) Journal of Medicinal Chemistry , vol.49 , Issue.24 , pp. 6972-6976
    • Hajduk, P.J.1
  • 42
    • 79960997906 scopus 로고    scopus 로고
    • Molecular complexity and fragment-based drug discovery: Ten years on
    • Leach AR, Hann MM. Molecular complexity and fragment-based drug discovery: ten years on. Curr Opin Chem Biol 2011;15:489-96
    • (2011) Curr Opin Chem Biol , vol.15 , pp. 489-496
    • Leach, A.R.1    Hann, M.M.2
  • 43
    • 39749181550 scopus 로고    scopus 로고
    • Generation of a set of simple, interpretable ADMET rules of thumb
    • DOI 10.1021/jm701122q
    • Gleeson MP. Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 2008;51:817-34 (Pubitemid 351304691)
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.4 , pp. 817-834
    • Gleeson, M.P.1
  • 44
    • 65449179589 scopus 로고    scopus 로고
    • Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower logD limits based on permeability
    • Waring MJ. Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower logD limits based on permeability. Bioorg Med Chem Lett 2009;19:2844-51
    • (2009) Bioorg Med Chem Lett , vol.19 , pp. 2844-2851
    • Waring, M.J.1
  • 45
    • 0034687231 scopus 로고    scopus 로고
    • Prediction of drug absorption using multivariate statistics
    • Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867-77
    • (2000) J Med Chem , vol.43 , pp. 3867-3877
    • Egan, W.J.1    Merz Jr., K.M.2    Baldwin, J.J.3
  • 46
    • 69949109727 scopus 로고    scopus 로고
    • Using the golden triangle to optimize clearance and oral absorption
    • Johnson TW, Dress KR, Edwards M. Using the golden triangle to optimize clearance and oral absorption. Bioorg Med Chem Lett 2009;19:5560-4
    • (2009) Bioorg Med Chem Lett , vol.19 , pp. 5560-5564
    • Johnson, T.W.1    Dress, K.R.2    Edwards, M.3
  • 47
    • 18244370266 scopus 로고    scopus 로고
    • A bioavailability score
    • DOI 10.1021/jm0492002
    • Martin YC. A bioavailability score. J Med Chem 2005;48:3164-70 (Pubitemid 40628036)
    • (2005) Journal of Medicinal Chemistry , vol.48 , Issue.9 , pp. 3164-3170
    • Martin, Y.C.1
  • 50
    • 34247245174 scopus 로고    scopus 로고
    • ADME evaluation in drug discovery. 6. Can oral biavailability in humans be effectively predicted by simple molecular property-based rules?
    • DOI 10.1021/ci6003515
    • Hou T, Wang J, Zhang W, Xu X. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J Chem Info Model 2007;47:460-3 (Pubitemid 46615948)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.2 , pp. 460-463
    • Hou, T.1    Wang, J.2    Zhang, W.3    Xu, X.4
  • 51
    • 49849094738 scopus 로고    scopus 로고
    • Physiochemical drug properties associated with in vivo toxicological outcomes
    • Hughes JD, Blagg J, Price DA, et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett 2008;18:4872-5
    • (2008) Bioorg Med Chem Lett , vol.18 , pp. 4872-485
    • Hughes, J.D.1    Blagg, J.2    Price, D.A.3
  • 52
    • 68149160053 scopus 로고    scopus 로고
    • Physicochemical drug properties associated with in vivo toxicological outcomes: A review
    • Price DA, Blagg J, Jones L, et al. Physicochemical drug properties associated with in vivo toxicological outcomes: a review. Expert Opin Drug Metab Toxicol 2009;5:921-31
    • (2009) Expert Opin Drug Metab Toxicol , vol.5 , pp. 921-931
    • Price, D.A.1    Blagg, J.2    Jones, L.3
  • 53
    • 77949375780 scopus 로고    scopus 로고
    • Biopharmaceutical drug targeting to the brain
    • Pardridge WM. Biopharmaceutical drug targeting to the brain. J Drug Target 2010;18:157-67
    • (2010) J Drug Target , vol.18 , pp. 157-167
    • Pardridge, W.M.1
  • 54
    • 21144467893 scopus 로고
    • Hydrogen-bonding capacity and brain penetration
    • van de Waterbeemd H, Kansy M. Hydrogen-bonding capacity and brain penetration. Chimia (Aarau) 1992;48:299-303
    • (1992) Chimia (Aarau) , vol.48 , pp. 299-303
    • Van De Waterbeemd, H.1    Kansy, M.2
  • 55
    • 0032795192 scopus 로고    scopus 로고
    • Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption
    • DOI 10.1021/js9804011
    • Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci 1999;88:807-14 (Pubitemid 29398550)
    • (1999) Journal of Pharmaceutical Sciences , vol.88 , Issue.8 , pp. 807-814
    • Clark, D.E.1
  • 56
    • 33845937770 scopus 로고    scopus 로고
    • Structure-brain exposure relationships
    • DOI 10.1021/jm060642i
    • Hitchcock S, Pennington L, Lin L, Lanza T Jr. Structure-brain exposure relationships. J Med Chem 2007;49:7559-83 (Pubitemid 46033646)
    • (2006) Journal of Medicinal Chemistry , vol.49 , Issue.26 , pp. 7559-7583
    • Hitchcock, S.A.1    Pennington, L.D.2
  • 57
    • 70350397386 scopus 로고    scopus 로고
    • Brain drug targeting: A computational approach for overcoming blood-brain barrier
    • Mehdipour AR, Hamidi M. Brain drug targeting: a computational approach for overcoming blood-brain barrier. Drug Discov Today 2009;14:1030-6
    • (2009) Drug Discov Today , vol.14 , pp. 1030-1036
    • Mehdipour, A.R.1    Hamidi, M.2
  • 58
    • 84856376107 scopus 로고    scopus 로고
    • Virtual ADMET Assessment in Target Selection and Maturation
    • Abraham M. In Silico Models to Predict Brain Uptake. Virtual ADMET Assessment in Target Selection and Maturation. 2005
    • (2005) Silico Models to Predict Brain Uptake
    • Abraham, M.1
  • 59
    • 0345117308 scopus 로고    scopus 로고
    • ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors
    • Hou TJ, Xu XJ. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J Chem Info comput sci 2003;43:2137-52
    • (2003) J Chem Info Comput Sci , vol.43 , pp. 2137-2152
    • Hou, T.J.1    Xu, X.J.2
  • 60
    • 67650070045 scopus 로고    scopus 로고
    • Multi-parameter phenotypic profiling: Using cellular effects to characterize small-molecule compounds
    • Feng Y, Mitchison TJ, Bender A, et al. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov 2009;8:567-78
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 567-578
    • Feng, Y.1    Mitchison, T.J.2    Bender, A.3
  • 61
    • 58149128997 scopus 로고    scopus 로고
    • Metabolite-likeness as a criterion in the design and selection of pharmaceutical drug libraries
    • Dobson PD, Patel Y, Kell DB. "Metabolite-likeness" as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 2009;14:31-40
    • (2009) Drug Discov Today , vol.14 , pp. 31-40
    • Dobson, P.D.1    Patel, Y.2    Kell, D.B.3
  • 62
    • 33745333814 scopus 로고    scopus 로고
    • Can 'bacterial-metabolite-likeness' model improve odds of 'in silico' antibiotic discovery?
    • DOI 10.1021/ci050480j
    • Cherkasov A. Can 'Bacterial-Metabolite-Likeness' model improve odds of 'in Silico' antibiotic discovery? J Chem Inf Model 2006;46:1214-22 (Pubitemid 43999165)
    • (2006) Journal of Chemical Information and Modeling , vol.46 , Issue.3 , pp. 1214-1222
    • Cherkasov, A.1
  • 63
    • 34247345395 scopus 로고    scopus 로고
    • Comparing the chemical spaces of metabolites and available chemicals: Models of metabolite-likeness
    • DOI 10.1007/s11030-006-9054-0
    • Gupta S, Aires-de-Sousa J. Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness. Mol Divers 2007;11:23-36 (Pubitemid 46639419)
    • (2007) Molecular Diversity , vol.11 , Issue.1 , pp. 23-36
    • Gupta, S.1    Aires-de-Sousa, J.2
  • 64
    • 0030756360 scopus 로고    scopus 로고
    • Reactive compounds and in vitro false positives in HTS
    • DOI 10.1016/S1359-6446(97)01083-0, PII S1359644697010830
    • Rishton G. Reactive compounds and in vitro false positives in HTS. Drug Discov Today 1997;9:382-4 (Pubitemid 27368216)
    • (1997) Drug Discovery Today , vol.2 , Issue.9 , pp. 382-384
    • Rishton, G.M.1
  • 66
    • 77950571108 scopus 로고    scopus 로고
    • New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and for their exclusion in bioassays
    • Baell JB, Holloway GA. New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719-40
    • (2010) J Med Chem , vol.53 , pp. 2719-2740
    • Baell, J.B.1    Holloway, G.A.2
  • 67
    • 77955349319 scopus 로고    scopus 로고
    • Genotoxic impurities: From structural alerts to qualification
    • Snodin DJ. Genotoxic impurities: from structural alerts to qualification. Org Process Res Dev 2010;14:960-76
    • (2010) Org Process Res Dev , vol.14 , pp. 960-976
    • Snodin, D.J.1
  • 68
    • 79960701365 scopus 로고    scopus 로고
    • Identification of toxifying and detoxifying moieties for mutagenicity prediction by priority assessment
    • Casalegno M, Benfenati E, Sello G. Identification of toxifying and detoxifying moieties for mutagenicity prediction by priority assessment. J Chem Inf Model 2011;51:1564-74
    • (2011) J Chem Inf Model , vol.51 , pp. 1564-1574
    • Casalegno, M.1    Benfenati, E.2    Sello, G.3
  • 69
    • 79960205454 scopus 로고    scopus 로고
    • Assessment of methods to define the applicability domain of structural alert models
    • Ellison CM, Sherhod R, Cronin MTD, et al. Assessment of methods to define the applicability domain of structural alert models. J Chem Inf Model 2011;51:975-85
    • (2011) J Chem Inf Model , vol.51 , pp. 975-985
    • Ellison, C.M.1    Sherhod, R.2    Mtd, C.3
  • 70
    • 80053004364 scopus 로고    scopus 로고
    • Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States
    • Stepan AF, Walker DP, Bauman J, et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 2011;24:1345-410
    • (2011) Chem Res Toxicol , vol.24 , pp. 1345-1410
    • Stepan, A.F.1    Walker, D.P.2    Bauman, J.3
  • 71
    • 79961119877 scopus 로고    scopus 로고
    • In silico toxicology models and databases as FDA critical path initiative toolkits
    • Valerio LG. In silico toxicology models and databases as FDA critical path initiative toolkits. Hum Genomics 2011;5:200-7
    • (2011) Hum Genomics , vol.5 , pp. 200-207
    • Valerio, L.G.1
  • 72
    • 13244266921 scopus 로고    scopus 로고
    • Lead- and drug-like compounds: The rule-of-five revolution
    • DOI 10.1016/j.ddtec.2004.11.007, PII S1740674904000551
    • Lipinski C. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337-41 (Pubitemid 40186335)
    • (2004) Drug Discovery Today: Technologies , vol.1 , Issue.4 , pp. 337-341
    • Lipinski, C.A.1
  • 73
    • 80052831391 scopus 로고    scopus 로고
    • Drug discovery in the next decade: Innovation needed ASAP
    • Bennani YL. Drug discovery in the next decade: innovation needed ASAP. Drug Discov Today 2011;16:779-92
    • (2011) Drug Discov Today , vol.16 , pp. 779-792
    • Bennani, Y.L.1
  • 74
    • 79851514658 scopus 로고    scopus 로고
    • Lead optimization in the nondrug-like space
    • Zhao H. Lead optimization in the nondrug-like space. Drug Discov Today 2011;16:158-63
    • (2011) Drug Discov Today , vol.16 , pp. 158-163
    • Zhao, H.1
  • 75
    • 78650746852 scopus 로고    scopus 로고
    • Methods for the synthesis of macrocycle libraries for drug discovery
    • Terrett NK. Methods for the synthesis of macrocycle libraries for drug discovery. Drug Discov Today Technol 2010;7:e97-e104
    • (2010) Drug Discov Today Technol , vol.7
    • Terrett, N.K.1
  • 76
    • 77956294635 scopus 로고    scopus 로고
    • Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
    • Bird GH, Madani N, Perry AF, et al. Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic. Proc Natl Acad Sci USA 2010;107:14093-8
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 14093-14098
    • Bird, G.H.1    Madani, N.2    Perry, A.F.3
  • 77
    • 77952542911 scopus 로고    scopus 로고
    • Current strategies for diversity-oriented synthesis
    • Dandapani S, Marcaurelle LA. Current strategies for diversity-oriented synthesis. Curr Opin Chem Biol 2010;14:362-70
    • (2010) Curr Opin Chem Biol , vol.14 , pp. 362-370
    • Dandapani, S.1    Marcaurelle, L.A.2
  • 79
    • 84856371528 scopus 로고    scopus 로고
    • In-silico assay for assessing phospholipidosis potential of small drug like molecules: Training, validation and refinement using several datasets
    • In press
    • Fischer H, Atzpodien EA, Csato M, et al. In-silico assay for assessing phospholipidosis potential of small drug like molecules: training, validation and refinement using several datasets. J Med Chem 2011; In press
    • (2011) J Med Chem
    • Fischer, H.1    Atzpodien, E.A.2    Csato, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.